Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03340207 · ClinicalTrials.gov registry record · NA
Novel Airway Device to Aid Endotracheal Intubations
A NA study, sponsored by University at Buffalo.
- Terminated
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT03340207 is a NA study that was terminated before completion, run by University at Buffalo. The registered enrollment target is 32 participants.
The verdict
NCT03340207, a NA study, was terminated before completion, sponsored by University at Buffalo.
- TERMINATED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
Pneumaglide is a device designed to facilitate intubation. Patients who are undergoing a surgical procedure under general anesthesia and will require placement of endotracheal tube will be screened and upon fulfilling the inclusion criteria will be randomized to PneumaGlide group or non-PneumaGlide group. After induction of anesthesia PneumaGlide device will placed in the mouth of the Pneumaglide assigned subject. The time for intubation will be measured from the time that the laryngoscope is inserted into the mouth until the trachea is successfully intubated and compared between the groups. Oxygen saturation drop below 90% and also gastric secretion spillage will be compared between two groups as well.
Interventions
- DEVICE Pneumaglide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2017-10-15 |
| Est. Completion | 2019-08-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03340207
The ClinicalTrials.gov registry entry for NCT03340207 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University at Buffalo, which has 67 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pneumaglide is the first listed.
NCT03340207 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03340207 about?
NCT03340207 is a clinical study titled "Novel Airway Device to Aid Endotracheal Intubations". Pneumaglide is a device designed to facilitate intubation. Patients who are undergoing a surgical procedure under general anesthesia and will require placement of endotracheal tube will be screened and upon fulfilling the inclusion criteria will be randomized to PneumaGlide group or non-PneumaGlide ...
What is the current status of trial NCT03340207?
This trial is currently terminated. It is a NA study. The enrollment target is 32 participants. The study started on 2017-10-15. Estimated completion is 2019-08-25.
What interventions are being tested in trial NCT03340207?
The interventions under investigation include: Pneumaglide (DEVICE).
Who is sponsoring clinical trial NCT03340207?
This trial is sponsored by University at Buffalo, which has 67 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.